E9F

4-(6-{1-[(R)-S-methanesulfonimidoyl]cyclopropyl}-2-[(3R)-3-methylmorpholin-4-yl]pyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridine

Created:	2021-12-06
Last modified:	2022-01-19

Find Related PDB Entry
1 entries where E9F is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	53
Chiral Atom Count	2
Bond Count	57
Aromatic Bond Count	16

2D diagram of E9F

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	4-(6-{1-[(R)-S-methanesulfonimidoyl]cyclopropyl}-2-[(3R)-3-methylmorpholin-4-yl]pyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridine
Systematic Name (OpenEye OEToolkits)	azanylidene-methyl-[1-[2-[(3~{R})-3-methylmorpholin-4-yl]-6-(1~{H}-pyrrolo[2,3-b]pyridin-4-yl)pyrimidin-4-yl]cyclopropyl]-oxidanylidene-$l^{6}-sulfane
Formula	C₂₀ H₂₄ N₆ O₂ S
Molecular Weight	412.509
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	CS(=N)(=O)C1(CC1)c1nc(nc(c1)c1ccnc2[NH]ccc21)N1CCOCC1C
SMILES	CACTVS	3.385	C[CH]1COCCN1c2nc(cc(n2)C3(CC3)[S](C)(=N)=O)c4ccnc5[nH]ccc45
SMILES	OpenEye OEToolkits	2.0.7	CC1COCCN1c2nc(cc(n2)C3(CC3)S(=N)(=O)C)c4ccnc5c4cc[nH]5
Canonical SMILES	CACTVS	3.385	C[C@@H]1COCCN1c2nc(cc(n2)C3(CC3)[S@](C)(=N)=O)c4ccnc5[nH]ccc45
Canonical SMILES	OpenEye OEToolkits	2.0.7	C[C@@H]1COCCN1c2nc(cc(n2)C3(CC3)S(=N)(=O)C)c4ccnc5c4cc[nH]5
InChI	InChI	1.03	InChI=1S/C20H24N6O2S/c1-13-12-28-10-9-26(13)19-24-16(14-3-7-22-18-15(14)4-8-23-18)11-17(25-19)20(5-6-20)29(2,21)27/h3-4,7-8,11,13,21H,5-6,9-10,12H2,1-2H3,(H,22,23)/t13-,29-/m1/s1
InChIKey	InChI	1.03	NQNZWWHMAAZKNQ-JYCIKRDWSA-N

Related Resource References

Resource Name	Reference
PubChem	162422441

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.